CWM
LPCN icon

Cornerstone Wealth Management’s Lipocine LPCN Stock Holding History

Cornerstone Wealth Management’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-941
Closed -$5.09K – 515
2023
Q1 		$5.09K Buy
+941
New +$7.27K ﹤0.01% 468

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cornerstone Wealth Management's LPCN Position: Q2 2023 in Review

Cornerstone Wealth Management sold out of Lipocine (LPCN) in Q2 2023, closing a stake of 941 shares — an estimated $5.09K sold.

Cornerstone Wealth Management first reported a position in LPCN in Q1 2023 and held it in 1 quarter. The position peaked at $5.09K in Q1 2023. 24 funds tracked by Wall St. Rank hold LPCN as of Q2 2023.

  • Cornerstone Wealth Management reported no remaining Lipocine position as of Q2 2023 after selling out during the quarter.
  • Cornerstone Wealth Management sold 941 Lipocine shares in Q2 2023, an estimated $5.09K.
  • Cornerstone Wealth Management first reported a position in Lipocine in Q1 2023 and held it in 1 quarter.
  • Cornerstone Wealth Management's Lipocine position peaked at $5.09K in Q1 2023.
  • 24 funds tracked by Wall St. Rank held Lipocine as of Q2 2023.

Based on Cornerstone Wealth Management's 13F filing for Q2 2023, filed 14 Jul 2023.